Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.04.07.647558

Genomic insights into polysaccharide substrate utilization and novel genera resource mining in macroalgal epiphytic bacteria

Abstract

Marine macroalgae, among the fastest photosynthesizing organisms, play a crucial role in the ocean carbon cycle by converting fixed carbon dioxide into polysaccharides. Macroalgal epiphytic bacteria possessing specific polysaccharide utilization loci (PULs) have a generalized polysaccharide degradation potential that facilitates their growth and colonization. In this study, we conducted extensive research on their polysaccharide degradation potential. Through sampled and purified epiphytic bacteria and metagenomic analysis revealed a high prevalence of novel genera and species. Two novel genera, 1117T and 3-347T, were taxonomically characterized and conducted detailed functional analyses. The results demonstrated that these genera possess abundant PULs and strong capabilities for synthesizing secondary metabolites. Furthermore, their high relative abundance on macroalgal surfaces aligns with global ecological distribution patterns. These traits facilitate their colonization, growth, and environmental adaptation on macroalgal surfaces. We further performed in-depth annotation of a large number of PULs and CAZyme genes of macroalgal epiphytic bacteria. Potential polysaccharide substrates for their degradation can be predicted and focused on. Additionally, we conducted growth curve analyses by starch, xylan, {beta}-1,3-glucan, and carboxymethyl cellulose substrates to validate the genomic predictions. In summary, our findings demonstrate that macroalgal epiphytic bacteria possess significant potential for degrading algal polysaccharides. This capability may enhance their competitiveness and survival probability on macroalgal surfaces. These bacteria, originating from different sources and genera, possess similar PULs, which may result from horizontal gene transfer or evolutionary relationships. ImportanceMacroalgae are major primary producers in coastal areas and their carbon sequestration capacity per unit area far exceeds that of terrestrial forests. In this work, we extensively studied macroalgal epiphytic bacteria with polysaccharide degradation potential. We found that epiphytic bacteria from different macroalgal sources and genera share similar PULs to degrade the same polysaccharide, which may be the result of horizontal gene transfer or evolutionary relationships. Core taxa on the macroalgal surface have gradually evolved polysaccharide-degrading abilities of different marine macroalgae in order to expand their colonization and survival chances. We also identified a large number of uncultivated algal biosphere species and unreported new genera and species for expansion of macroalgal epiphytic bacteria studies. These studies have thus highlighted the important ecological and research value of macroalgal epiphytic bacteria, especially in influencing polysaccharide carbon storage and marine carbon cycling.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Liu, T., Zhou, H.-Y., Zhang, H.-Z., Wang, F.-Q., Liu, Y.-Z., Teng, J.-H., Fan, S.-J., Lu, D.-C., Du, Z.. 2025-04-07. Genomic insights into polysaccharide substrate utilization and novel genera resource mining in macroalgal epiphytic bacteria. https://doi.org/10.1101/2025.04.07.647558

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology↗

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology↗

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology↗